4//SEC Filing
Tak Paul Peter 4
Accession 0000899243-22-037231
CIK 0001841387other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 6:30 PM ET
Size
9.8 KB
Accession
0000899243-22-037231
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-11-28+195,906→ 220,906 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on November 28, 2023, and the remaining 50% on November 28, 2024, in each case subject to the Reporting Person's continued service on such vesting date.
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873905
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 6:30 PM ET
- Size
- 9.8 KB